Oral Fingolimod (FTY720) Treatment Improves the Performance of Daily Activities Compared with Intramuscular Interferon beta-1a: Patient-Reported Indices for Multiple Sclerosis (PRIMUS)-Activities Results from a Phase III Study (TRANSFORMS)

J. Cohen, F. Barkhof, G. Comi, H.P. Hartung, L. Kappos, B. Khatri, X. Montalban, J. Pelletier, T. Stites, S. Wu, J. Jin, B. Eckert

Research output: Contribution to journalMeeting AbstractOther research output

Original languageUndefined/Unknown
Pages (from-to)A543-A544
Issue number9
Publication statusPublished - 2010

Cite this